S
Shanghai Rightongene Biotechnology Co Ltd
SSE:688217
Shanghai Rightongene Biotechnology Co Ltd
SSE:688217
Price:
27.22
CNY
-2.68%
Market Closed
Market Cap:
¥1.5B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
Shanghai Rightongene Biotechnology Co Ltd
SSE:688217
|
CN |
|
Macy's Inc
NYSE:M
|
US |
|
Sinopec Engineering Group Co Ltd
HKEX:2386
|
CN |
|
Diebold Nixdorf Inc
NYSE:DBD
|
US |
|
Creative Vistas Inc
OTC:CVAS
|
CA |
|
V
|
VerticalScope Holdings Inc
TSX:FORA
|
CA |
|
S
|
Strauss Group Ltd
TASE:STRS
|
IL |
|
Duran Dogan Basim Ve Ambalaj Sanayi AS
IST:DURDO.E
|
TR |
|
ATS Corp
TSX:ATS
|
CA |
|
O
|
Okong Corp
KOSDAQ:045060
|
KR |
|
T
|
Triton Development SA
WSE:TRI
|
PL |
|
Valero Energy Corp
NYSE:VLO
|
US |
|
A
|
Anhui Korrun Co Ltd
SZSE:300577
|
CN |
|
XiAn Catering Co Ltd
SZSE:000721
|
CN |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Shanghai Rightongene Biotechnology Co Ltd's stock price target?
Not Available
Shanghai Rightongene Biotechnology Co Ltd doesn't have any price targets made by Wall Street professionals.
What is Shanghai Rightongene Biotechnology Co Ltd's Revenue forecast?
Projected CAGR
37%
37%
For the last 5 years the compound annual growth rate for Shanghai Rightongene Biotechnology Co Ltd's revenue is -1%. The projected CAGR for the next 2 years is 37%.
